ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program

OBJECTIVES: To assess a novel application of the Prostate Health Index (phi) and biopsy tissue DNA content in benign-adjacent and cancer areas to predict which patients would eventually require treatment of prostate cancer in the Proactive Surveillance cohort. METHODS: We identified 71 men who had h...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Urology
Hlavní autoři: Isharwal, Sumit, Makarov, Danil V., Sokoll, Lori J., Landis, Patricia, Marlow, Cameron, Epstein, Jonathan I., Partin, Alan W., Carter, H. Ballentine, Veltri, Robert W.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2011
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4696012/
https://ncbi.nlm.nih.gov/pubmed/21216447
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urology.2010.07.526
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky